CSTONE PHARMA-B 02616·

Gross margin --------------------56.17%--57.83%1.67%65.60%7.77%58.98%6.63%19.01%39.97% Net margin ---------------------787.84%---187.53%600.31%-79.17%108.35%-22.40%56.77%-162.10%139.71% ROE -34.53%---72.46%37.93%-------------159.08%---200.90%41.82%-80.39%120.51%-25.07%55.32%-70.85%45.79% ROA -30.63%---60.71%30.08%-------------84.53%---55.09%29.44%-22.10%33.00%-6.55%15.55%-32.17%25.63% Revenue growth ------------------------97.51%---3.64%101.15%-12.21%8.57%-33.80%21.59% Attributable profit growth -----25.52%------------------52.99%--59.32%6.33%75.16%15.85%-379.13%454.30% Debt-to-assets 7.16%--20.07%12.90%------------46.86%--72.58%25.71%72.51%0.06%73.89%1.37%54.59%19.29% Current ratio 13.94--4.829.12------------2.10--1.320.781.560.251.600.032.180.58 Operating cash flow / net profit 0.84--0.700.14------------0.77--0.680.101.600.933.321.720.752.57 Operating cash flow / revenue ---------------------608.91%---126.88%482.03%-126.95%0.07%-74.46%52.49%-121.58%47.11%

Gross margin -187.64%--45.93%233.57% Net margin -546.37%---123.01%423.36% Revenue growth ----314.75%-- Attributable profit growth ----6.62%-- Debt-to-assets ----37.13%-- Current ratio ----3.58--

Revenue --------------------243.72M--481.36M97.51%463.84M3.64%407.20M12.21%269.58M33.80% Other income and gains 187.00K--9.19M4811.76%------------45.77M--18.72M59.10%50.61M170.31%27.06M46.53%25.51M5.71% Gross profit --------------------136.89M--278.38M103.36%304.30M9.31%240.15M21.08%51.25M78.66% Selling and distribution expenses --------------------363.79M--327.30M10.03%199.35M39.09%133.78M32.89%83.34M37.70% Administrative expenses 15.05M--39.34M161.36%------------297.60M--249.06M16.31%182.71M26.64%77.80M57.42%89.02M14.42% Net finance costs 240.00K--60.00K75.00%------------2.24M--8.48M278.10%11.82M39.42%15.17M28.33%13.27M12.49% Income tax ------------------------------------13.06M-- Operating profit ---------------------1.92B---894.20M53.38%-355.42M60.25%-76.04M78.61%-410.67M440.07% Profit before tax ---------------------1.92B---902.68M52.99%-367.23M59.32%-91.21M75.16%-423.94M364.81% Net profit -253.04M---342.55M35.37%-------------1.92B---902.68M52.99%-367.23M59.32%-91.21M75.16%-437.00M379.13% Net profit attributable to owners -246.09M---308.90M25.52%-------------1.92B---902.68M52.99%-367.23M59.32%-91.21M75.16%-437.00M379.13%

Revenue 49.45M--205.10M314.75% Other income and gains 9.31M--15.99M71.63% Cost of sales 142.24M--110.90M22.03% Gross profit -92.79M--94.20M201.52% Selling and distribution expenses 35.65M--73.11M105.07% Administrative expenses 43.55M--51.32M17.84% Net finance costs 6.91M--5.12M25.81% Net profit -270.18M---252.28M6.62% Net profit attributable to owners -270.18M---252.28M6.62%

Cash and cash equivalents 59.54M--83.39M40.06%------------742.72M--558.68M24.78%996.67M78.40%387.94M61.08%753.70M94.28% Trade and bills receivables --------------------117.60M--77.13M34.41%172.44M123.56%83.93M51.33%33.81M59.71% Inventories --------------------61.36M--22.19M63.84%108.83M390.48%286.10M162.89%116.89M59.14% Total current assets 824.82M--545.26M33.89%------------1.96B--1.25B36.31%1.33B6.65%1.09B18.04%1.11B2.14% Total assets 826.14M--564.28M31.70%------------2.27B--1.64B27.87%1.66B1.44%1.39B16.16%1.36B2.52% Total current liabilities 59.18M--113.23M91.32%------------932.95M--946.48M1.45%850.34M10.16%682.01M19.80%510.22M25.19% Total liabilities 59.18M--113.23M91.32%------------1.06B--1.19B11.71%1.21B1.35%1.03B14.57%741.60M27.97% Equity attributable to owners 712.69M--426.34M40.18%------------1.21B--449.33M62.77%456.83M1.67%363.87M20.35%616.77M69.50% Total equity 766.96M--451.05M41.19%------------1.21B--449.33M62.77%456.83M1.67%363.87M20.35%616.77M69.50%

Cash and cash equivalents ----1.40B-- Trade and bills receivables ----107.36M-- Inventories ----74.17M-- Total current assets ----1.81B-- Total assets ----2.06B-- Total current liabilities ----504.62M-- Total liabilities ----763.49M-- Equity attributable to owners ----1.29B-- Total equity ----1.29B--

Net cash from operating activities -213.01M---240.19M12.76%-------------1.48B---610.74M58.85%-588.84M3.59%-303.21M48.51%-327.75M8.09% Net cash from investing activities -753.47M--268.30M135.61%-------------826.55M--363.39M143.96%619.61M70.51%-247.68M139.97%133.99M154.10% Net cash from financing activities 1.01B---300.00K100.03%------------92.30M--28.47M69.16%388.36M1264.23%-52.86M113.61%577.78M1192.95% Net change in cash 44.03M--27.81M36.83%-------------2.22B---218.88M90.13%419.12M291.48%-603.76M244.05%384.02M163.60%